Björn Dahlbäck

Seniorprofessor
Fler filtreringsmöjligheter
  1. 2021
  2. Pleiotropic anticoagulant functions of protein S, consequences for the clinical laboratory. Communication from the SSC of the ISTH

    Herm Jan M. Brinkman, Josefin Ahnström, Elisabetta Castoldi, Björn Dahlbäck & Richard A. Marlar, 2021, I: Journal of Thrombosis and Haemostasis. 19, 1, s. 281-286 6 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. 2020
  4. Advances in understanding mechanisms of thrombophilic disorders

    Björn Dahlback, 2020, I: Hämostaseologie. 40, 1, s. 12-21 10 s.

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  5. Reduced Apolipoprotein M and Adverse Outcomes across the Spectrum of Human Heart Failure

    Julio A. Chirinos, Lei Zhao, Yi Jia, Cecilia Frej, Luigi Adamo, Douglas Mann, Swapnil V. Shewale, John S. Millar, Daniel J. Rader, Benjamin French, Jeff Brandimarto, Kenneth B. Margulies, John S. Parks, Zhaoqing Wang, Dietmar A. Seiffert, James Fang, Nancy Sweitzer, Christina Chistoffersen, Björn Dahlbäck, Bruce D. Car & 3 andra, David A. Gordon, Thomas P. Cappola & Ali Javaheri, 2020, I: Circulation. s. 1463-1476 14 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. 2019
  7. New functional test for the TFPIα cofactor activity of Protein S working in synergy with FV-Short

    Björn Dahlbäck, Li Jun Guo, Bengt Zöller & Sinh Tran, 2019, I: Journal of Thrombosis and Haemostasis. 17, 4, s. 585-595

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  8. Plasma Apolipoprotein M and Sphingosine-1-Phosphate Levels are Inversely Associated with Mortality in African Americans with Type 2 Diabetes Mellitus

    M Liu, Cecilia Frej, Carl D. Langefeld, Jasmin Divers, Donald W. Bowden, JJ Carr, AK Gebre, J Xu, Benny Larsson, Björn Dahlbäck, Barry I. Freedman & John S. Parks, 2019, I: Journal of Lipid Research. 60, 8, s. 1425-1431

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. 2018
  10. Lean ApoM−/− Mice with Hyperactive Brown Adipose Tissue

    Björn Dahlbäck, 2018 maj, I: Trends in Endocrinology and Metabolism. 29, 5, s. 283-284

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. Treating hemophilia by targeting protein S?

    Björn Dahlbäck, 2018 mar 22, I: Blood. 131, 12, s. 1271-1272 2 s.

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  12. Vitamin K–Dependent Protein S: Beyond the Protein C Pathway

    Björn Dahlbäck, 2018 mar, I: Seminars in Thrombosis and Hemostasis. 44, 2, s. 176-184

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. High-density lipoprotein from end-stage renal disease patients exhibits superior cardioprotection and increase in sphingosine-1-phosphate

    Jonas W. Brinck, Aurélien Thomas, Marie Claude Brulhart-Meynet, Estelle Lauer, Cecilia Frej, Björn Dahlbäck, Peter Stenvinkel, Richard W. James & Miguel A. Frias, 2018 feb, I: European Journal of Clinical Investigation. 48, 2, e12866.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  14. 2017
  15. Factor V-short and protein S as synergistic tissue factor pathway inhibitor (TFPIα) cofactors

    Björn Dahlbäck, Li Jun Guo, Ruzica Livaja Koshiar & Sinh Tran, 2017 dec 20, I: Research and practice in thrombosis and haemostasis. 2, 1, s. 114-124

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  16. Novel insights into the regulation of coagulation by factor V isoforms, tissue factor pathway inhibitorα, and protein S

    B. Dahlbäck, 2017 jul 1, I: Journal of Thrombosis and Haemostasis. 15, 7, s. 1241-1250 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  17. A Shift in ApoM/S1P between HDL-Particles in Women with Type 1 Diabetes Mellitus Is Associated with Impaired Anti-Inflammatory Effects of the ApoM/S1P Complex

    Cecilia Frej, Armando J. Mendez, Mario Ruiz Garcia, Melanie Castillo, Thomas A. Hughes, Björn Dahlbäck & Ronald B. Goldberg, 2017 jun 1, I: Arteriosclerosis, Thrombosis, and Vascular Biology. 37, 6, s. 1194-1205

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. Implications of cerebrovascular ATP-binding cassette transporter G1 (ABCG1) and apolipoprotein M in cholesterol transport at the blood-brain barrier

    Alexandra Carmen Kober, Anil Paul Chirackal Manavalan, Carmen Tam-Amersdorfer, Andreas Holmér, Ahmed Saeed, Elham Fanaee-Danesh, Martina Zandl, Nicole Maria Albrecher, Ingemar Björkhem, Gerhard M. Kostner, Björn Dahlbäck & Ute Panzenboeck, 2017 jun 1, I: Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids. 1862, 6, s. 573-588 16 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  19. The nanoparticle protein corona formed in human blood or human blood fractions

    Martin Lundqvist, Cecilia Augustsson, Malin Lilja, Kristoffer Lundkvist, Björn Dahlbäck, Sara Linse & Tommy Cedervall, 2017 apr 1, I: PLoS ONE. 12, 4, e0175871.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. HDL-associated ApoM is anti-apoptotic by delivering sphingosine 1-phosphate to S1P1 & S1P3 receptors on vascular endothelium

    Mario Ruiz Garcia, Hiromi Okada & Björn Dahlbäck, 2017 feb 8, I: Lipids in Health and Disease. 16, 1, 36.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  21. High-Density Lipoprotein–Associated Apolipoprotein M Limits Endothelial Inflammation by Delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1

    Mario Ruiz Garcia, Cecilia Frej, Andreas Holmér, Li J. Guo, Sinh Tran & Björn Dahlbäck, 2017 jan, I: Arteriosclerosis, Thrombosis, and Vascular Biology. 37, 1, s. 118-129

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  22. Diminished airway macrophage expression of the Axl receptor tyrosine kinase is associated with defective efferocytosis in asthma

    Aleksander M. Grabiec, Nicholas Denny, John A. Doherty, Kaisa E. Happonen, Jenny Hankinson, Emma Connolly, Mark E. Fife, Toshifumi Fujimori, Naoya Fujino, Anu Goenka, Susan Holden, Gaël Tavernier, Rajesh Shah, Peter C. Cook, Andrew S. MacDonald, Robert M. Niven, Björn Dahlbäck, Stephen J. Fowler, Angela Simpson & Tracy Hussell, 2017, I: Journal of Allergy and Clinical Immunology. 140, 4, s. 1144-1146.e4

    Forskningsoutput: TidskriftsbidragLetter

  23. Gas6-Axl signaling in presence of Sunitinib is enhanced, diversified and sustained in renal tumor cells, resulting in tumor-progressive advantages

    Anna Gustafsson, Helena K M Fritz & Björn Dahlbäck, 2017, I: Experimental Cell Research. 355, 1, s. 47-56

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  24. 2016
  25. Familial hypercholesterolaemia: cholesterol efflux and coronary disease

    Jorie Versmissen, Ranitha Vongpromek, Reyhana Yahya, Jeroen B. van der Net, Leonie van Vark-van der Zee, Jeannette Blommesteijn-Touw, Darcos Wattimena, Trinet Rietveld, Clive R. Pullinger, Christina Christoffersen, Björn Dahlbäck, John P. Kane, Monique Mulder & Eric J G Sijbrands, 2016 jul 1, I: European Journal of Clinical Investigation. 46, 7, s. 643-650 8 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  26. Sphingosine 1-phosphate and its carrier apolipoprotein M in human sepsis and in Escherichia coli sepsis in baboons

    Cecilia Frej, Adam Linder, Kaisa E. Happonen, Fletcher B. Taylor, Florea Lupu & Björn Dahlbäck, 2016 jun 1, I: Journal of Cellular and Molecular Medicine. 20, 6, s. 1170-1181 12 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  27. The Gas6-Axl Interaction Mediates Endothelial Uptake of Platelet Microparticles

    Kaisa E Happonen, Sinh Tran, Matthias Mörgelin, Raja Prince, Sara Calzavarini, Anne Angelillo-Scherrer & Björn Dahlbäck, 2016 mar 22, I: Journal of Biological Chemistry. 291, 20, s. 10586-10601

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  28. Gas6 fueling tumor-mediated thrombosis.

    Kaisa Happonen & Björn Dahlbäck, 2016, I: Blood. 127, 6, s. 672-673

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  29. Urinary apolipoprotein M as a biomarker of acute kidney injury in children undergoing heart surgery.

    Eva Martha Madsen Svarrer, Henrik Ørbæk Andersen, Morten Helvind, Maartje Cj Slagman, Gerjan Navis, Robin Pf Dullaart, Björn Dahlbäck & Lars Bo Nielsen, 2016, I: Biomarkers in Medicine. 10, 1, s. 81-93

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  30. 2015
  31. Amino acid residues in the laminin G domains of protein S involved in tissue factor pathway inhibitor interaction.

    Sofia Somajo, Josefin Ahnström, J Fernandez-Recio, M Gierula, B O Villoutreix & Björn Dahlbäck, 2015, I: Thrombosis and Haemostasis. 113, 5, s. 976-987

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  32. HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation.

    Sylvain Galvani, Marie Sanson, Victoria A Blaho, Steven L Swendeman, Heather Conger, Björn Dahlbäck, Mari Kono, Richard L Proia, Jonathan D Smith & Timothy Hla, 2015, I: Science Signaling. 8, 389, s. ra79

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  33. Protein Unfolding allow use of Commercial Antibodies in an Apolipoprotein M sandwich ELISA.

    Markus Hoeybye Bosteen, Björn Dahlbäck, Lars Bo Nielsen & Christina Christoffersen, 2015, I: Journal of Lipid Research. 56, 3, s. 754-759

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  34. Quantification of sphingosine 1-phosphate by validated LC-MS/MS method revealing strong correlation with apolipoprotein M in plasma but not in serum due to platelet activation during blood coagulation.

    Cecilia Frej, Anders S Andersson, Benny Larsson, Li Jun Guo, Eva Norström, Kaisa Happonen & Björn Dahlbäck, 2015, I: Analytical and Bioanalytical Chemistry. 407, 28, s. 8533-8542

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  35. The Axl-Regulating Tumor Suppressor miR-34a Is Increased in ccRCC but Does Not Correlate with Axl mRNA or Axl Protein Levels.

    Helena Fritz, Anna Gustafsson, Börje Ljungberg, Yvonne Ceder, Håkan Axelson & Björn Dahlbäck, 2015, I: PLoS ONE. 10, 8, e0135991.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  36. 2014
  37. Erythrocyte-derived microparticles supporting activated protein C-mediated regulation of blood coagulation.

    Ruzica Livaja Koshiar, Sofia Somajo, Eva Norström & Björn Dahlbäck, 2014, I: PLoS ONE. 9, 8, e104200.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  38. Protein S and factor V in regulation of coagulation on platelet microparticles by activated protein C.

    Sofia Somajo, Ruzica Livaja Koshiar, Eva Norström & Björn Dahlbäck, 2014, I: Thrombosis Research. 134, 1, s. 144-152

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  39. Size-Dependent Effects of Nanoparticles on Enzymes in the Blood Coagulation Cascade.

    Elodie Sanfins, Cecilia Augustsson, Björn Dahlbäck, Sara Linse & Tommy Cedervall, 2014, I: Nano Letters. 14, 8, s. 4736-4744

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  40. Targeting exosites of activated protein C as therapeutic possibility?

    Björn Dahlbäck, 2014, I: Thrombosis Research. 133, 6, s. 963-964

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  41. TFPI cofactor function of protein S: essential role of the protein S SHBG-like domain

    Natalia Reglinska-Matveyev, Helena M. Andersson, Suely M. Rezende, Björn Dahlbäck, James T. B. Crawley, David A. Lane & Josefin Ahnstroem, 2014, I: Blood. 123, 25, s. 3979-3987

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  42. The miR(21/10b) ratio as a prognostic marker in clear cell renal cell carcinoma.

    Helena Fritz, David Lindgren, Börje Ljungberg, Håkan Axelson & Björn Dahlbäck, 2014, I: European Journal of Cancer. 50, 10, s. 1758-1765

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  43. 2013
  44. Coagulation factor V-A2440G causes east Texas bleeding disorder via TFPI alpha

    Lisa M. Vincent, Sinh Tran, Ruzica Livaja Koshiar, Tracy A. Bensend, Dianna M. Milewicz & Björn Dahlbäck, 2013, I: Journal of Clinical Investigation. 123, 9, s. 3777-3787

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  45. Molecular basis of coagulation factor V deficiency caused by the R1698W inter-domain mutation

    Sara Calzavarini, Bruno O. Villoutreix, Barbara Lunghi, Ruzica Livaja Koshiar, Francesco Bernardi & Björn Dahlbäck, 2013, I: Thrombosis and Haemostasis. 110, 1, s. 31-38

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  46. 2012
  47. Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL

    Sara Elsoe, Josefin Ahnstrom, Christina Christoffersen, Andrew N. Hoofnagle, Peter Plomgaard, Jay W. Heinecke, Christoph J. Binder, Harry Björkbacka, Björn Dahlbäck & Lars B. Nielsen, 2012, I: Atherosclerosis. 221, 1, s. 91-97

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  48. Biocompatibility of mannan nanogel-safe interaction with plasma proteins

    Silvia A. Ferreira, Cecilia Oslakovic, Risto Cukalevski, Birgitta Frohm, Björn Dahlbäck, Sara Linse, Francisco M. Gama & Tommy Cedervall, 2012, I: Biochimica et Biophysica Acta. General Subjects. 1820, 7, s. 1043-1051

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  49. Coagulation and inflammation-close allies in health and disease.

    Björn Dahlbäck, 2012, I: Seminars in Immunopathology. 34, s. 1-3

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  50. Decreased plasma concentrations of apolipoprotein M in sepsis and systemic inflammatory response syndromes

    Sunil Kumaraswamy, Adam Linder, Per Åkesson & Björn Dahlbäck, 2012, I: Critical Care. 16, 2, R60.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  51. Polystyrene nanoparticles affecting blood coagulation.

    Cecilia Oslakovic, Tommy Cedervall, Sara Linse & Björn Dahlbäck, 2012, I: Nanomedicine: Nanotechnology, Biology and Medicine. 8, 6, s. 981-986

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  52. Small and large PROS1 deletions but no other types of rearrangements detected in patents with protein S deficiency

    Christina Lind-Hallden, Anna Dahlen, Andreas Hillarp, Bengt Zöller, Björn Dahlbäck & Christer Hallden, 2012, I: Thrombosis and Haemostasis. 108, 1, s. 94-100

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  53. The plasma concentration of HDL-associated apoM is influenced by LDL receptor-mediated clearance of apoB-containing particles

    Christina Christoffersen, Marianne Benn, Pernille M. Christensen, Philip L. S. M. Gordts, Anton J. M. Roebroek, Ruth Frikke-Schmidt, Anne Tybjaerg-Hansen, Björn Dahlbäck & Lars B. Nielsen, 2012, I: Journal of Lipid Research. 53, 10, s. 2198-2204

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Föregående 1 2 3 4 5 6 Nästa